[Estimation of efficiency of anti-helicobacter therapy in patients with a chronic pancreatitis combined with an erosive gastropathy].

@article{Koval2014EstimationOE,
  title={[Estimation of efficiency of anti-helicobacter therapy in patients with a chronic pancreatitis combined with an erosive gastropathy].},
  author={Valeriy Koval' and L A Kotsiubniak and O M Moskal'},
  journal={Wiadomosci lekarskie},
  year={2014},
  volume={67 2 Pt 2},
  pages={335-7}
}
SUMMARY Eradikacion therapy at patients with chronic pancreatitis and combined with Helicobacter associated erosive gastropathy in a month after treatment appeared successful at 75% patients which accepted therapy of the first line--pantoprazol, amoksicillin, klaritromicin. Inclusion in antihelicobakter therapy of seknidazol in place of klaritromicin… CONTINUE READING